- Service Name
RootPath Genomics
- Industry
Biotechnology, Gene Synthesis, Synthetic Biology, Precision Medicine
- Main Value Proposition
RootPath offers unprecedented access to synthetic genes and their functional readouts, significantly enhancing the throughput of gene function interrogation.
- Description
RootPath Genomics is a biotechnology company that specializes in synthetic biology, providing advanced solutions for gene synthesis and functional interrogation. Their platform enables researchers and drug developers to access accurate, long synthetic genes and their functional readouts at scale.
- Key Features
Length of genes from 300 bp to 10 kb; Complexity-agnostic gene synthesis; Affordable pricing starting from $0.03/bp for individual genes; Functional screening services available from $15 per test
- Use Cases
RootPath's services are most valuable for researchers and drug developers looking to synthesize genes, create mutagenesis libraries, and conduct functional screenings for T cell therapies.
- Competitive advantages
Cost-effective pricing for gene synthesis and libraries; Rapid lead times of 10 business days for gene delivery; Comprehensive services including functional screening and combinatorial libraries
- Strengths
RootPath's strengths lie in its innovative technology, competitive pricing, and ability to deliver complex gene synthesis solutions quickly and efficiently.
- Positioning
RootPath positions itself as a leader in synthetic biology, providing scalable solutions for gene synthesis and functional interrogation.
- Audience
The primary target users include researchers in synthetic biology, drug developers, and academic institutions focused on genetic research and therapy development.
- CTA
Learn more
- Tags
gene synthesis
synthetic biology
functional screening
T cell therapy
- Tagline
Enabling biology at scale
- Tone of Voice
Innovative, professional, accessible
- Differentiation
RootPath's unique molecular programming-based DNA fragment assembly technology allows for high-throughput gene synthesis and functional analysis, setting it apart from traditional gene synthesis providers.
- Brand Positioning
RootPath identifies itself as a cutting-edge biotechnology company that bridges the gap between precision medicine and synthetic biology.
- Founded
2017-01-01
- Founders
Cheryl Cui
Ely Porter
Le Cong
Xi Chen
Yinquing Li